wall street a late round of computerdriven sell programmes pushed us equity prices sharply lower on a day in which the market had largely held its own in spite of an erosion in ibms share price writes karen zagor in new york the dow jones industrial average closed 2242 lower at 331084 after gaining more than 18 points in the afternoon the more broadly based standard poors 500 fell 117 to 43798 while the amex composite was down 035 at 39383 the nasdaq composite however climbed 276 to 66901 trading volume on the new york se was more than 215m shares and rises outnumbered declines by 988 to 825 on monday the dow had closed 702 higher at 33326 on thin volume wall streets morning buoyancy was the result of several factors including betterthanexpected existing home sales for november a strong consumer confidence index and endofyear window dressing by money managers the consumer confidence index for december rose to 783 from 656 in november while the national association of realtors said existing home sales rose 58 per cent in november in addition the last week of the year is traditionally a strong period for the stock market ibm fell dollars 2 to dollars 49 34 in active trading after merrill lynch cut its longterm investment rating on the stock to above average from buy the dow also came under pressure from heavy selling in minnesota mining manufacturing attributed to profit taking the issue closed dollars 2 34 lower at dollars 100 18 among other active blue chips att added dollars 38 to dollars 52 14 a 52week high philip morris lost dollars 38 to dollars 77 78 and disney fell dollars 18 to dollars 44 18 shares in tiffany the upmarket us jeweller soared dollars 3 58 to dollars 33 18 on news that several analysts had upgraded investment ratings on monday tiffany reported an 8 per cent rise in sales for the eight week holiday period shares in cordis a company which makes specialised medical devices climbed dollars 58 to a 52week high of dollars 36 38 the food drug administration approved us marketing of the companys sleuth xt and ptca dilation catheters news that the fda had approved the marketing of taxol a promising new cancer drug derived from the pacific yew tree helped shares in bristolmyers advance dollars 34 to dollars 68 12 bristolmyers has received permission to market taxol to women with ovarian cancer who have failed to respond to chemotherapy canada toronto ended little changed in active trading boosted by a large block trade in international verifact inc shares based on preliminary data the 300 composite index was down 504 points or 015 per cent to 331487 with advances leading declines 316 to 223 volume rose to 4083m shares compared with 1601m at thursdays halfday session canadian markets were closed friday and monday for the christmas and boxing day holidays